5 Subjects must discontinue use of steroids muscle relaxants anticonvulsants sodium channel blockers topical analgesics and needle-based therapies including trigger point injections and acupuncture at least 1 week prior to starting study medication and agree to stay off such therapies throughout the study Continuation of nonsteroidal anti-inflammatories antidepressants and opiates are allowed provided they have reached a stable dose prior to study entry and maintain a stable dose throughout the study 